The role of complement in antibody-mediated rejection in kidney transplantation. - Wikidata - wikimedia - TriplyDB

The role of complement in antibody-mediated rejection in kidney transplantation.

The role of complement in antibody-mediated rejection in kidney transplantation.

http://www.wikidata.org/entity/Q38048605

about

An Insight Into the Immunologic Events and Risk Assessment in Renal Transplantation Monoclonal antibody therapy and renal transplantation: focus on adverse effects The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation Effects of complement activation on allograft injury The importance of C4d in biopsies of kidney transplant recipients Issues in solid-organ transplantation in children: translational research from bench to bedside.Unraveling the Role of Allo-Antibodies and Transplant Injury Allograft Rejection The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies.Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera from Subjects Dosed with the Anti-C1s Monoclonal Antibody TNT009 - Results from a Randomized First-in-Human Phase 1 Trial.Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant.Increased Circulating T Lymphocytes Expressing HLA-DR in Kidney Transplant Recipients with Microcirculation Inflammation.Assessment of Circulating Protein Signatures for Kidney Transplantation in Pediatric Recipients.Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.Successful management of repetitive urinary obstruction and anuria caused by double j stent calculi formation after renal transplantation Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss.Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.Clinical impact of H-Y alloimmunity Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.Complement involvement in kidney diseases: From physiopathology to therapeutical targeting Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians Rational clinical trial design for antibody mediated renal allograft injury.An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA Applying complement therapeutics to rare diseases.IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival.Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients Inhibition of complement improves graft outcome in a pig model of kidney autotransplantation.Combined integrated protocol/basket trial design for a first-in-human trial.Lessons and limits of mouse models.Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation Heparin/heparan sulphate interactions with complement--a possible target for reduction of renal function loss?Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantation.Antibody-mediated rejection in liver transplantation: current controversies and future directions.Transplant glomerulopathy: the interaction of HLA antibodies and endothelium Graft microvascular disease in solid organ transplantation.Antibody-mediated rejection despite inhibition of terminal complement.Banff 2013 update: Pearls and pitfalls in transplant renal pathology.Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

P2860

Q26747765-C083FF2A-413E-468D-B779-61498A318E10 Q26826880-EC7EB48B-187F-49E8-94F6-8DAFD32884D2 Q26862195-F0F519D0-EE26-4938-8B69-0EF19F646276 Q26863724-57EA838D-273F-4899-AA8A-862D4850AB11 Q26995453-CF9BDF55-CEEF-4D88-9E50-9606B404530B Q27021227-FDD6EC43-D189-4C45-A30E-7299E29EED11 Q27023312-F19FECC0-B96E-4AE2-8170-A4566CDFEAA4 Q28069336-5799E22A-38C4-49C4-966D-7BC82DDCA8C4 Q30225484-709F33A7-6D39-47B5-94A9-3E6400E266F1 Q30397251-087AFA33-8BF8-45C7-A624-7AC607F02D62 Q30491939-585878CF-B32F-449D-B96D-696E31731D53 Q33412869-3402B636-4F3B-4773-B253-BF214DA3EB57 Q33661464-E9E13724-E428-458A-9D72-3E9F44242831 Q33804303-A67E6E65-C286-4305-A549-700D4C51AB26 Q33804736-BF3E4BCC-8983-4271-BBC6-B1F9251F29D2 Q33942678-DC9BC954-C8A0-4C8E-A0AB-3B8F543A1765 Q33998148-89701EB7-FB68-4266-96BA-CA19AF10AE5A Q35027253-6F4E0679-861B-428C-B371-B7945495713F Q35235186-C9EC582E-6796-4C80-9E93-67E38EFA4ECD Q35236103-3F83CEAC-DB0B-4510-90EA-BE18CFD7C2C5 Q35567841-CA290E95-C5F4-40B0-A573-ECCB0B9A01A7 Q36007256-D24CFD68-2C4B-4EF5-92D8-BE1837AF8196 Q36173541-B211FCEC-2407-4CBC-921C-566F342113EB Q36302476-D6706B5F-DC2E-49AE-9F7E-2D613705EFC6 Q36315497-F171F1BE-36A3-425B-8404-EFE0F7619E93 Q36417907-865AB0F7-ADC7-4C12-80DF-BF8918174FDD Q36514864-3265E630-C481-4B6E-9D1A-2986A43B19A5 Q37013494-37EC1D34-E2E5-492A-9DA0-98C350E36A0F Q37280720-A78A1F20-D089-47B8-B31F-BD61A94068AE Q37310971-9BF0DBF4-AF3A-4574-9330-999056CF4D34 Q37340373-7EE74743-42AD-4CC6-81C0-CEFE6B9F95AB Q37616457-954D55A1-B74F-4FF4-BFF9-D2EFA752036A Q38123661-25422385-DE83-4646-9B44-B32190915525 Q38168293-35A746F1-1CAF-42BE-9A07-D04FBD1A7DED Q38182527-26F3E845-D635-4A8D-847B-9A09DC21927B Q38205229-B1DC45ED-4EB5-4F7A-8F9B-ECE7A7C453C9 Q38216381-D05550D0-4B8A-405F-9AEC-84D9F533299A Q38427447-E77EB1D4-08E7-4C04-9A20-8446175014A8 Q38510972-285ABF2C-CEEE-43F6-851D-82C2BF762C96 Q38592520-13CB7278-8153-4BB4-BFEC-4AE8E8AE07A1

P2860

The role of complement in antibody-mediated rejection in kidney transplantation.

http://www.wikidata.org/entity/Q38048605

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The role of complement in antibody-mediated rejection in kidney transplantation.

@en

type

label

The role of complement in antibody-mediated rejection in kidney transplantation.

@en

prefLabel

The role of complement in antibody-mediated rejection in kidney transplantation.

@en

P1433

Q38048605-D2CC78FC-FF48-4A21-82DB-087D283C4F39

P1476

Q38048605-C3C6709B-14C9-4119-842B-8A0A411D131F

P2093

Q38048605-802A4B12-8B0B-44FF-A407-F785D51E3AC4

Q38048605-D141AA90-6545-468A-A7D7-140366AB6733

Q38048605-FA185BB4-711A-43DF-AD00-1467AC89F2F5

P2860

Q38048605-02DBE9EA-58A4-4636-8D31-D6FB69B6DEAE

Q38048605-288D53A7-B7CF-4C23-8F80-0766E8A9AB4A

Q38048605-2E822025-BE62-41DA-8F33-35718E658E5B

Q38048605-3128B94E-B292-4C34-82A7-C37FCED8FB79

Q38048605-328A2ED5-A052-4357-BC61-CEEFC5B8FEE3

Q38048605-3664EB45-9392-4746-90EE-5A80A8D09BE7

Q38048605-3F15762C-A233-4299-9E45-384B14077C0B

Q38048605-478B1F4D-DEC2-42D6-9464-AFA078AA3B84

Q38048605-497DFE5D-974A-4F50-9266-F0E428BEF445

Q38048605-49F54F0A-776E-475C-9B51-86BE3934D56E

P2888

Q38048605-F17DD6F7-4974-4EE7-ADF4-10336F129DB8

P304

Q38048605-DEBC90FC-DD59-446F-BAD0-AA45B271B2EB

P31

Q38048605-3E862319-5DDE-4050-B502-944ECCEC46B7

P356

Q38048605-DEFDD1DE-B7C3-4F31-BBB1-7948CEE6EFB0

P407

Q38048605-2FF9C1BC-C2AE-4538-83F3-04DAFC0B98B4

P433

Q38048605-64C86DDC-068B-4F21-A029-E3E1E858165D

P478

Q38048605-D20E8C76-3F9E-4B9F-939A-0E6C343571AB

P577

Q38048605-287BCDFC-6FBC-4494-AB24-2CC408D51098

P5875

Q38048605-8E2588BE-43CD-4641-A68F-8FD784489131

P698

Q38048605-6B0F68A5-B562-4900-A9F5-FFD5950D50BE

P921

Q38048605-621DD7B3-AB52-4AA1-B13A-995BE15858B2

P356

NRNEPH.2012.212

P1433

Nature Reviews Nephrology

P1476

The role of complement in antibody-mediated rejection in kidney transplantation.

@en

P2093

Lynn D Cornell

http://www.w3.org/2001/XMLSchema#string

Marcio F Chedid

http://www.w3.org/2001/XMLSchema#string

Mark D Stegall

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection

Pros and cons for C4d as a biomarker.

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Increased local concentration of complement C5a contributes to incisional pain in mice.

Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner.

Why hasn't eliminating acute rejection improved graft survival?

Kidney transplantation: mechanisms of rejection and acceptance.

P2888

nrneph.2012.212

P304

670-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEPH.2012.212

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231741646

http://www.w3.org/2001/XMLSchema#string

P698

23026942

http://www.w3.org/2001/XMLSchema#string

P921